MS Amadeus Silver III


">

Current Topics in Women’s Health

Start Date : October 24, 2019
End Date : October 31, 2019
Time : 9:00 am to8:00 am

Phone : 18004220711
Email : registrar@continuingeducation.net

Description

Topics:

  1. THE EVOLUTION OF CERVICAL CANCER SCREENING

    • The healthcare provider will recognize the development of modern day cervical cancer screening, the role of high risk HPV in male and female lower genital tract, oropharyngeal, anal carcinogenesis, and the importance of promoting HPV vaccination.



  2. BRIDGING THE PERIMENOPAUSAL GAP WITHOUT ESTROGEN

    • The clinician will address the concerns of perimenopausal women including their complaints of mood disturbance, vasomotor symptoms, insomnia, diminished sexual desire, vaginal atrophy. He/She will offer patients a variety of behavioral, hormonal, nonhormonal therapeutic modalities during this perimenopausal window.



  3. THE ADNEXAL MASS

    • The provider will describe the new model of ovarian carcinogenesis and the obstacles encountered in trying to develop ovarian cancer screening.

    • The participant will assess the malignant potential of a palpable mass in a woman using present day imaging and ovarian tumor markers and direct appropriate conservative, medical, or surgical intervention.



  4. FUNCTIONAL HYPOTHALAMIC AMENORRHEA and THE FEMALE ATHLETE TRIAD

    • By attending this educational event, healthcare providers will screen their patients for the Female Athlete Triad using 2014 Triad Consensus Panel recommendations and diagnose childhood, adolescent, and premenopausal osteopenia/osteoporosis.

    • The provider will also initiate early interventions including referrals to a sports dietitian, exercise physiologist, certified athletic trainer and mental health professional when indicated.



  5. THE PCOS LOOK-ALIKES

    • Participants will generate a differential diagnosis for females of various reproductive ages presenting with signs of hyperandrogenism and order appropriate laboratory, radiologic imaging and timely referral to an endocrinologist, gynecologic oncologist, or general surgeon.



  6. POLYCYSTIC OVARY SYNDROME

    • Upon completion of this didactic activity, the attendee will identify patients with PCOS, initiate recommended metabolic screening endorsed by the 2013 Endocrine Society and employ treatment for signs of hyperandrogenism.

    • The participant will also prescribe risk reducing behavioral and pharmacotherapeutic measures for long term sequela of this disorder.



  7. THE EVALUATION AND TREATMENT OF FEMALE URINARY INCONTINENCE

    • Attendees will differentiate the types of female urinary incontinence and provide appropriate counseling on causes and treatment options available including behavioral modification, pelvic floor rehabilitation, drug therapy and urogynecological/neurological referral.



  8. THE OVERACTIVE BLADDER

    • Participants will diagnose overactive bladder according to the 2014 Guidelines of the American Urological Association and prescribe a step-wise treatment plan for his/her patients with this disorder.



  9. UNDERSTANDING PELVIC ORGAN PROLAPSE

    • The provider will list the symptoms associated with female pelvic floor disorders, the proper evaluation and terminology of female genital prolapse and direct non-surgical treatment including the use of vaginal support devices (pessaries) or make appropriate urogynecological referral.



  10. THE BURNING VULVA SYNDROME

    • The participant will give examples of the variety of infectious, inflammatory, neoplastic, and neurologic disorders that cause vulvar burning/ pruritus, and make timely decisions on proper treatment and need for biopsy.



  11. MANAGEMENT OF THE PESKY VAGINAL DISCHARGE

    • The participant will draw from historical and physical exam findings, culture and new quantitative PCR based assays to properly detect and treat a variety of recurrent infectious and non-infectious causes of vaginal irritative symptoms.



  12. FEMALE SEXUAL CONCERNS

    • The attendee will openly discuss problems of a sexual nature with his/her patients, define the type of sexual dysfunction and offer behavioral, pharmacologic therapy or referral to sex therapist.



  13. TIME TO RAISE THE HCG DISCRIMINATORY LEVEL FOR NORMAL INTRAUTERINE PREGNANCY

    • To decrease the risk of interrupting a desired normal IUP, the provider will define the hCG discriminatory level as high as 3,500 mIU/mL before expecting to find an intrauterine gestational sac on TVS.



  14. Reclassifying Abnormal Uterine Bleeding, the Role of Endometrial biopsy and Novel Medical Therapy for Fibroids.

    • Attendees will adopt the PALM-COEIN classification system in defining the etiology of abnormal uterine bleeding in a nonpregnant woman of reproductive age. Additionally, participants will be able to select the most appropriate and cost effective imaging studies to confirm a specific disorder and direct endometrial biopsy based on patient specific risk factors.

    • The provider will recognize the potential role of new GnRH receptor antagonists, selective progesterone receptor modulators and the levonorgestrel-IUD in treating AUB-L



Registration Info

Go to

https://continuingeducation.net/coursedescription.php?topic=Womens_Health_Classical_Rhine_CME_River_Cruise_Conference_October_2019

or call 1-800-422-0711

Contact the Organizer

Organized by

Organized by KHenegar09

Continuing Education, Inc ,
5700 4th St. N.

Aboard MS Amadeus Silver III


Tel: 18004220711
Mobile: 18004220711
Email: registrar@continuingeducation.net
Website: http://www.continuingeducation.net


Event Categories: Gynecology and Obstetrics.

Your Review

You must be logged in to post a comment.